Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
6.93
-0.52 (-6.98%)
At close: Oct 23, 2026, 4:00 PM EDT
6.93
0.00 (0.00%)
Pre-market: Oct 26, 2026, 5:36 AM EDT
Avalo Therapeutics Employees
Avalo Therapeutics had 33 employees as of December 31, 2025. The number of employees increased by 10 or 43.48% compared to the previous year. That makes Avalo Therapeutics the 36,767th largest employer in the world and 5,080th in the United States.
Employees
33
Change (1Y)
10
Growth (1Y)
43.48%
Revenue / Employee
$1,788
Profits / Employee
-$3,040,394
Market Cap
371.66M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 33 | 10 | 43.48% | 33 | 0 |
| Dec 31, 2024 | 23 | 4 | 21.05% | 23 | 0 |
| Dec 31, 2023 | 19 | -1 | -5.00% | 19 | 0 |
| Dec 31, 2022 | 20 | -24 | -54.55% | 20 | 0 |
| Dec 31, 2021 | 44 | 13 | 41.94% | 42 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Capricor Therapeutics | 231 |
| ARS Pharmaceuticals | 200 |
| C4 Therapeutics | 104 |
| Editas Medicine | 87 |
| Prelude Therapeutics | 79 |
| TRex Bio | 60 |
| Tectonic Therapeutic | 60 |
| Fennec Pharmaceuticals | 35 |
AVTX News
- 2 days ago - Avalo Therapeutics price target lowered to $22 from $34 at Wedbush - TheFly
- 2 days ago - Avalo Therapeutics downgraded to Neutral at Guggenheim after AbbVie data - TheFly
- 2 days ago - Avalo Therapeutics price target lowered to $10 from $58 at BTIG - TheFly
- 2 days ago - Avalo Therapeutics downgraded to Neutral from Buy at H.C. Wainwright - TheFly
- 2 days ago - Avalo Therapeutics downgraded to Neutral from Buy at Guggenheim - TheFly
- 3 days ago - Avalo Therapeutics trading resumes - TheFly
- 3 days ago - Avalo Therapeutics trading halted, volatility trading pause - TheFly
- 26 days ago - Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire